Physician profile
Gordon Avery
NPI 1407874290
$1,294.93
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $48.62 · 2021: $102 · 2022: $484 · 2023: $186 · 2024: $78.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243 · Education: $21.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.41 |
| Education | $21.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $431.83 | 2020-2023 | Acufex |
| Innovation Technologies INC | $150.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $145.08 | 2022 | |
| Depuy Synthes Sales INC. | $132.52 | 2019-2023 | Velys |
| Bioventus LLC | $94.23 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $61.78 | 2019 | |
| Stryker Corporation | $40.95 | 2019-2021 | |
| Linvatec Corporation | $40.43 | 2022 | |
| Ethicon US, LLC | $26.19 | 2019 | |
| Collegium Pharmaceutical, INC. | $22.52 | 2024 | Xtampza |
| Arteriocyte Medical Systems, INC. | $22.28 | 2020 | |
| Vericel Corporation | $21.37 | 2023 | Maci |
| Fidia Pharma USA INC. | $19.41 | 2024 | Hymovis |
| Avanos Medical | $18.16 | 2019 | |
| Averitas Pharma INC. | $17.45 | 2023 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.41 | 2019 | |
| Daiichi Sankyo INC. | $16.23 | 2019 | |
| Heraeus Medical, LLC. | $11.40 | 2019 | |
| Orthofix Medical, INC. | $6.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Avery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.